Part of new models of care

2026

Designing healthcare transformation: a hybrid model between the hospital and home for high-risk pregnant womenPutievsky Pilosof N, Yoeli-Ullman R, Toussia-Cohen S, et al. Front Digit Health 2026;8:1797655

Sheba Beyond’s hybrid high-risk pregnancy unit uses INVU by Nuvo for fetal heart tracing (206 admissions, Oct 2023 to Dec 2025).

Sheba Medical Center

Article ↗PDF ↓Summary →

2025

Hybrid remote and in-clinic maternal-fetal surveillance for women with gestational diabetes: a prospective pilot studyAxelrod M, Lahav Ezra H, Galler E, et al. Int J Gynaecol Obstet 2025;170(1):430–8

Sheba used INVU for the NST in its hybrid gestational-diabetes programme; patients rated INVU 9.4 of 10.

Sheba Medical Center

Article ↗Summary →

2024

Study of fetal health outcomes: working with a Missouri e-telehealth platform (the SHOW-ME study)ClinicalTrials.gov NCT06741735 · recruiting

University of Missouri study with INVU as the home-monitoring arm, at three Missouri sites.

Sponsor: University of Missouri

Trial record ↗

2023

Remote pregnancy monitoring to improve access (REACTIVE)ClinicalTrials.gov NCT05847790 · completed 2025

Randomized trial at Penn Medicine of remote NSTs with INVU versus office NSTs in high-risk pregnancies.

Sponsor: University of Pennsylvania

Trial record ↗

The papers above, in plain language

2 summaries

We wrote short, plain-language summaries of 2 of the 4 papers on this page. Each one opens the summary, with a link to the full paper inside. In the list above, look for “Summary →”.